Mount Desert Island Biological Lab’s scientists: Kevin Strange, Voot Yin and their collaborator Michael Zasloff have been awarded a patent for MSI-1436, a potential new heart disease drug that stimulates the repair and regeneration of heart tissue damaged by injuries like a heart attack, according to MaineBiz. This is the first patent for the lab. Prof. Kevin Strange, MDIBL’s president says: “The importance of this achievement cannot be overstated. This patent is a critical step forward in our ability to develop new treatments for those who suffer from heart disease (…)”. Read full story
MDI Biological Lab Earns Its First Patent For Heart Repair Medicine
Related Posts
On the Record: Startup aims to turn scientific researchers into ‘deep-tech’ entrepreneurs
Justin Hafner, founder and former CEO of digital health startup Kinotek, aims to make an even bigger splash in the startup world...
Skincare startup funds UMaine scholarship to spark innovation
Marin Skincare, known for its Lobster Lotion product, partnered with the University of Maine to create a scholarship to spur innovation and...
Bigelow Lab looks to create ‘blue’ biotechnology businesses and jobs
Bigelow Laboratory for Ocean Sciences, an East Boothbay nonprofit research institute focused on global ocean health, last week launched a program...